Index by author
August 01, 1995; Volume 274,Issue 2
A
Abete, P
- You have accessProtective role of chronic ubiquinone administration on acute cardiac oxidative stress.N Ferrara, P Abete, G Ambrosio, P Landino, P Caccese, P Cirillo, A Oradei, G P Littarru, M Chiariello and F RengoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 858-865;
Ahern, G P
- You have accessBlockade of a resting potassium channel and modulation of synaptic transmission by ecstasy in the hippocampus.L S Premkumar and G P AhernJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 718-722;
Akkermans, L M
- You have accessCisapride and structural analogs selectively enhance 5-hydroxytryptamine (5-HT)-induced purinergic neurotransmission in the guinea pig proximal colon.M R Briejer, G J Veen, L M Akkermans, R A Lefebvre and J A SchuurkesJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 641-648;
Akunne, H C
- You have accessCI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.T A Rugsley, M D Davis, H C Akunne, L W Cooke, S Z Whetzel, R G MacKenzie, Y H Shih, D H van Leeuwen, S B DeMattos and L M GeorgicJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 898-911;
Albuquerque, E X
- You have accessDiversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current.M Alkondon and E X AlbuquerqueJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 771-782;
Alkondon, M
- You have accessDiversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current.M Alkondon and E X AlbuquerqueJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 771-782;
Ambrosio, G
- You have accessProtective role of chronic ubiquinone administration on acute cardiac oxidative stress.N Ferrara, P Abete, G Ambrosio, P Landino, P Caccese, P Cirillo, A Oradei, G P Littarru, M Chiariello and F RengoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 858-865;
Anderson, J J
- You have accessThe neurokinin1 receptor antagonist CP-99,994 reduces catalepsy produced by the dopamine D2 receptor antagonist raclopride: correlation with extracellular acetylcholine levels in striatum.J J Anderson, S Randall and T N ChaseJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 928-936;
Ansay, M
- You have accessEndogenous nitric oxide modulates acetylcholine-induced edema and vasoconstriction in isolated perfused rabbit lungs.A Delaunois, P Gustin and M AnsayJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 559-597;
ANSAY, M.
- You have accessEndogenous Nitric Oxide Modulates Acetylcholine-induced Edema and Vasoconstriction in Isolated Perfused Rabbit LungsA. DELAUNOIS, P. GUSTIN and M. ANSAYJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 589-597;
Aretha, C W
- You have accessDopamine D3-preferring ligands act at synthesis modulating autoreceptors.C W Aretha, A Sinha and M P GallowayJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 609-613;
Argentieri, T M
- You have accessAcute administration of 17 beta-estradiol inhibits calcium currents in isolated guinea pig detrusor myocytes.J H Sheldon and T M ArgentieriJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 723-729;
Ashforth, E I
- You have accessPrediction of in vivo disposition from in vitro systems: clearance of phenytoin and tolbutamide using rat hepatic microsomal and hepatocyte data.E I Ashforth, D J Carlile, R Chenery and J B HoustonJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 761-766;
B
Ban, K
- You have accessIrsogladine activates gap-junctional intercellular communication through M1 muscarinic acetylcholine receptor.F Ueda, K Ban and T IshimaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 815-819;
Barjavel, M J
- You have accessAnalgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat.F Stain, M J Barjavel, P Sandouk, M Plotkine, J M Scherrmann and H N BhargavaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 852-857;
Barrett, J E
- You have accessModification of the behavioral effects of (+/-)BAY k 8644, cocaine and d-amphetamine by L-type calcium channel blockers in squirrel monkeys.S Rosenzweig-Lipson and J E BarrettJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 842-851;
Barron, E
- You have accessCharacterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma.C D Nicholson, M Shahid, J Bruin, E Barron, I Spiers, J de Boer, R G van Amsterdam, J Zaagsma, J J Kelly and G DentJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 678-687;
Barry, S
- You have accessComparison of the distinct effects of epidermal growth factor and betamethasone on the morphogenesis of the gas exchange region and differentiation of alveolar type II cells in lungs of fetal rhesus monkeys.L A Edwards, L C Read, S J Nishio, A J Weir, W Hull, S Barry, D Styne, J A Whitsett, A F Tarantal and C George-NascimentoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 1025-1032;
Bemis, K
- You have accessPharmacological analysis of the noradrenergic control of central sympathetic and somatic reflexes controlling the lower urinary tract in the anesthetized cat.H Danuser, K Bemis and K B ThorJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 820-825;
Bennett, G J
- You have accessSynthetic omega-conopeptides applied to the site of nerve injury suppress neuropathic pains in rats.W H Xiao and G J BennettJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 666-672;
Bernstein, D
- You have accessColchicine and cytochalasin B enhance cyclic AMP accumulation via postreceptor actions.J R Jasper, S R Post, K H Desai, P A Insel and D BernsteinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 937-942;
Bhargava, H N
- You have accessAnalgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat.F Stain, M J Barjavel, P Sandouk, M Plotkine, J M Scherrmann and H N BhargavaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 852-857;
Blower, P
- You have accessThe piglet as a suitable animal model for studying the delayed phase of cisplatin-induced emesis.S Milano, P Blower, D Romain and L GrélotJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 951-961;
Borrelli, A R
- You have accessNeuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemia.G C Palmer, E C Cregan, A R Borrelli, E W Harris, M L Stagnitto, P Colombo, F C Kaiser, R J Murray, R C Griffith and J C StrandJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 991-1000;
Bose, R
- You have accessEffects of phenamil on potassium and calcium channels of guinea pig ventricular myocytes.A Guia, N Leblanc and R BoseJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 649-656;
Boucher, J L
- You have accessNitric oxide formation during the cytochrome P-450-dependent reductive metabolism of 18-nitro-oxyandrostenedione.M Delaforge, A Piffeteau, J L Boucher and A VigerJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 634-640;
Bowyer, J F
- You have accessAmphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects.P Clausing, B Gough, R R Holson, W Slikker and J F BowyerJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 614-621;
Briejer, M R
- You have accessCisapride and structural analogs selectively enhance 5-hydroxytryptamine (5-HT)-induced purinergic neurotransmission in the guinea pig proximal colon.M R Briejer, G J Veen, L M Akkermans, R A Lefebvre and J A SchuurkesJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 641-648;
Brink, C
- You have accessEndothelin-1 modulates cyclic GMP production and relaxation in human pulmonary vessels.G Pussard, J P Gascard, I Gorenne, C Labat, X Norel, E Dulmet and C BrinkJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 969-975;
Bronstein, D M
- You have accessEffects of sulpiride and SCH 23390 on methamphetamine-induced changes in body temperature and lethality.D M Bronstein and J S HongJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 943-950;
Bruin, J
- You have accessCharacterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma.C D Nicholson, M Shahid, J Bruin, E Barron, I Spiers, J de Boer, R G van Amsterdam, J Zaagsma, J J Kelly and G DentJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 678-687;
Bullock, A E
- You have accessSodium channel blockers partially inhibit nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomes.M J Marks, A E Bullock and A C CollinsJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 833-841;
Bunney, B S
- You have accessRitanserin, a 5-HT2A/2C antagonist, reverses direct dopamine agonist-induced inhibition of midbrain dopamine neurons.W X Shi, P Nathaniel and B S BunneyJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 735-740;
Butelman, E R
- You have accessEffects of morphine and ketorolac on thermal allodynia induced by prostaglandin E2 and bradykinin in rhesus monkeys.S S Negus, E R Butelman, M B Gatch and J H WoodsJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 805-814;
C
Caccese, P
- You have accessProtective role of chronic ubiquinone administration on acute cardiac oxidative stress.N Ferrara, P Abete, G Ambrosio, P Landino, P Caccese, P Cirillo, A Oradei, G P Littarru, M Chiariello and F RengoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 858-865;
Carlile, D J
- You have accessPrediction of in vivo disposition from in vitro systems: clearance of phenytoin and tolbutamide using rat hepatic microsomal and hepatocyte data.E I Ashforth, D J Carlile, R Chenery and J B HoustonJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 761-766;
Carlisle, M A
- You have accessEfaroxan acts peripherally to block the antisecretory and gastroprotective effects of moxonidine in rats.M A Carlisle, D D Smyth and G B GlavinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 598-601;
- You have accessAgmatine, an endogenous imidazoline receptor agonist, increases gastric secretion and worsens experimental gastric mucosal injury in rats.G B Glavin, M A Carlisle and D D SmythJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 741-744;
Chase, T N
- You have accessThe neurokinin1 receptor antagonist CP-99,994 reduces catalepsy produced by the dopamine D2 receptor antagonist raclopride: correlation with extracellular acetylcholine levels in striatum.J J Anderson, S Randall and T N ChaseJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 928-936;
Chenery, R
- You have accessPrediction of in vivo disposition from in vitro systems: clearance of phenytoin and tolbutamide using rat hepatic microsomal and hepatocyte data.E I Ashforth, D J Carlile, R Chenery and J B HoustonJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 761-766;
Chiariello, M
- You have accessProtective role of chronic ubiquinone administration on acute cardiac oxidative stress.N Ferrara, P Abete, G Ambrosio, P Landino, P Caccese, P Cirillo, A Oradei, G P Littarru, M Chiariello and F RengoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 858-865;
Christoffersen, C L
- You have accessCI-1007, a dopamine partial agonist and potential antipsychotic agent. II. Neurophysiological and behavioral effects.L T Meltzer, C L Christoffersen, A E Corbin, F W Ninteman, K A Serpa, J N Wiley, L D Wise and T G HeffnerJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 912-920;
Cirillo, P
- You have accessProtective role of chronic ubiquinone administration on acute cardiac oxidative stress.N Ferrara, P Abete, G Ambrosio, P Landino, P Caccese, P Cirillo, A Oradei, G P Littarru, M Chiariello and F RengoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 858-865;
Clausing, P
- You have accessAmphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects.P Clausing, B Gough, R R Holson, W Slikker and J F BowyerJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 614-621;
Collins, A C
- You have accessSodium channel blockers partially inhibit nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomes.M J Marks, A E Bullock and A C CollinsJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 833-841;
Colombo, P
- You have accessNeuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemia.G C Palmer, E C Cregan, A R Borrelli, E W Harris, M L Stagnitto, P Colombo, F C Kaiser, R J Murray, R C Griffith and J C StrandJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 991-1000;
Colton, M D
- You have accessHuman prostate muscarinic receptor subtypes.M R Ruggieri, M D Colton, P Wang, J Wang, R J Smyth, M A Pontari and G R LuthinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 976-982;
Cooke, L W
- You have accessCI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.T A Rugsley, M D Davis, H C Akunne, L W Cooke, S Z Whetzel, R G MacKenzie, Y H Shih, D H van Leeuwen, S B DeMattos and L M GeorgicJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 898-911;
Corbin, A E
- You have accessCI-1007, a dopamine partial agonist and potential antipsychotic agent. II. Neurophysiological and behavioral effects.L T Meltzer, C L Christoffersen, A E Corbin, F W Ninteman, K A Serpa, J N Wiley, L D Wise and T G HeffnerJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 912-920;
Cregan, E C
- You have accessNeuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemia.G C Palmer, E C Cregan, A R Borrelli, E W Harris, M L Stagnitto, P Colombo, F C Kaiser, R J Murray, R C Griffith and J C StrandJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 991-1000;
D
Danuser, H
- You have accessPharmacological analysis of the noradrenergic control of central sympathetic and somatic reflexes controlling the lower urinary tract in the anesthetized cat.H Danuser, K Bemis and K B ThorJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 820-825;
Davis, M D
- You have accessCI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.T A Rugsley, M D Davis, H C Akunne, L W Cooke, S Z Whetzel, R G MacKenzie, Y H Shih, D H van Leeuwen, S B DeMattos and L M GeorgicJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 898-911;
Davis, T P
- You have accessNeuropeptide metabolism on intact, regional brain slices: effect of dopaminergic agents on substance P, cholecystokinin and Met-enkephalin degradation.S M Waters, C S Konkoy and T P DavisJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 783-789;
de Boer, J
- You have accessCharacterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma.C D Nicholson, M Shahid, J Bruin, E Barron, I Spiers, J de Boer, R G van Amsterdam, J Zaagsma, J J Kelly and G DentJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 678-687;
Delaforge, M
- You have accessNitric oxide formation during the cytochrome P-450-dependent reductive metabolism of 18-nitro-oxyandrostenedione.M Delaforge, A Piffeteau, J L Boucher and A VigerJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 634-640;
Delaunois, A
- You have accessEndogenous nitric oxide modulates acetylcholine-induced edema and vasoconstriction in isolated perfused rabbit lungs.A Delaunois, P Gustin and M AnsayJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 559-597;
DELAUNOIS, A.
- You have accessEndogenous Nitric Oxide Modulates Acetylcholine-induced Edema and Vasoconstriction in Isolated Perfused Rabbit LungsA. DELAUNOIS, P. GUSTIN and M. ANSAYJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 589-597;
DeMattos, S B
- You have accessCI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.T A Rugsley, M D Davis, H C Akunne, L W Cooke, S Z Whetzel, R G MacKenzie, Y H Shih, D H van Leeuwen, S B DeMattos and L M GeorgicJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 898-911;
Dent, G
- You have accessCharacterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma.C D Nicholson, M Shahid, J Bruin, E Barron, I Spiers, J de Boer, R G van Amsterdam, J Zaagsma, J J Kelly and G DentJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 678-687;
Desai, K H
- You have accessColchicine and cytochalasin B enhance cyclic AMP accumulation via postreceptor actions.J R Jasper, S R Post, K H Desai, P A Insel and D BernsteinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 937-942;
Do, M L
- You have accessZENECA ZD6169: a novel KATP channel opener with in vivo selectivity for urinary bladder.B B Howe, T J Halterman, C L Yochim, M L Do, S J Pettinger, R B Stow, C J Ohnmacht, K Russell, J R Empfield and D A TrainorJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 884-890;
Drewe, J
- You have accessEnteral absorption of octreotide: modulation of intestinal permeability by distinct carbohydrates.G Fricker and J DreweJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 826-832;
Dulmet, E
- You have accessEndothelin-1 modulates cyclic GMP production and relaxation in human pulmonary vessels.G Pussard, J P Gascard, I Gorenne, C Labat, X Norel, E Dulmet and C BrinkJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 969-975;
E
Eckert, R
- You have accessInhibition of L-type calcium currents in guinea pig ventricular myocytes by the kappa-opioid agonist U50488H does not involve binding to opiate receptors.J Utz, R Eckert and W TrautweinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 627-633;
Edwards, L A
- You have accessComparison of the distinct effects of epidermal growth factor and betamethasone on the morphogenesis of the gas exchange region and differentiation of alveolar type II cells in lungs of fetal rhesus monkeys.L A Edwards, L C Read, S J Nishio, A J Weir, W Hull, S Barry, D Styne, J A Whitsett, A F Tarantal and C George-NascimentoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 1025-1032;
Edwards, M A
- You have accessEffects of N-methyl-D-aspartate antagonists in rats discriminating different doses of cocaine: comparison with direct and indirect dopamine agonists.K M Kantak, M A Edwards and R D SpealmanJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 657-665;
Empfield, J R
- You have accessZENECA ZD6169: a novel KATP channel opener with in vivo selectivity for urinary bladder.B B Howe, T J Halterman, C L Yochim, M L Do, S J Pettinger, R B Stow, C J Ohnmacht, K Russell, J R Empfield and D A TrainorJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 884-890;
F
Ferrara, N
- You have accessProtective role of chronic ubiquinone administration on acute cardiac oxidative stress.N Ferrara, P Abete, G Ambrosio, P Landino, P Caccese, P Cirillo, A Oradei, G P Littarru, M Chiariello and F RengoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 858-865;
Forenza, S
- You have accessTubulin polymerization by paclitaxel (taxol) phosphate prodrugs after metabolic activation with alkaline phosphatase.S W Mamber, A B Mikkilineni, E J Pack, M P Rosser, H Wong, Y Ueda and S ForenzaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 877-883;
Fricker, G
- You have accessEnteral absorption of octreotide: modulation of intestinal permeability by distinct carbohydrates.G Fricker and J DreweJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 826-832;
Friedman, H
- You have accessdelta 9-Tetrahydrocannabinol (THC) causes the variable expression of IL2 receptor subunits.W Zhu, T Igarashi, H Friedman and T W KleinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 1001-1007;
Fujimoto, J M
- You have accessCold water swim stress- and delta-2 opioid-induced analgesia are modulated by spinal gamma-aminobutyric acidA receptors.P Killian, B B Holmes, A E Takemori, P S Portoghese and J M FujimotoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 730-734;
Fukuhara, N
- You have accessInvolvement of dopamine, N-methyl-D-aspartate and sigma receptor mechanisms in methamphetamine-induced anticipatory activity rhythm in rats.S Shibata, M Ono, N Fukuhara and S WatanabeJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 688-694;
G
Galloway, M P
- You have accessDopamine D3-preferring ligands act at synthesis modulating autoreceptors.C W Aretha, A Sinha and M P GallowayJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 609-613;
Gascard, J P
- You have accessEndothelin-1 modulates cyclic GMP production and relaxation in human pulmonary vessels.G Pussard, J P Gascard, I Gorenne, C Labat, X Norel, E Dulmet and C BrinkJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 969-975;
Gatch, M B
- You have accessEffects of morphine and ketorolac on thermal allodynia induced by prostaglandin E2 and bradykinin in rhesus monkeys.S S Negus, E R Butelman, M B Gatch and J H WoodsJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 805-814;
George-Nascimento, C
- You have accessComparison of the distinct effects of epidermal growth factor and betamethasone on the morphogenesis of the gas exchange region and differentiation of alveolar type II cells in lungs of fetal rhesus monkeys.L A Edwards, L C Read, S J Nishio, A J Weir, W Hull, S Barry, D Styne, J A Whitsett, A F Tarantal and C George-NascimentoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 1025-1032;
Georgic, L M
- You have accessCI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.T A Rugsley, M D Davis, H C Akunne, L W Cooke, S Z Whetzel, R G MacKenzie, Y H Shih, D H van Leeuwen, S B DeMattos and L M GeorgicJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 898-911;
Glavin, G B
- You have accessEfaroxan acts peripherally to block the antisecretory and gastroprotective effects of moxonidine in rats.M A Carlisle, D D Smyth and G B GlavinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 598-601;
- You have accessAgmatine, an endogenous imidazoline receptor agonist, increases gastric secretion and worsens experimental gastric mucosal injury in rats.G B Glavin, M A Carlisle and D D SmythJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 741-744;
Gorenne, I
- You have accessEndothelin-1 modulates cyclic GMP production and relaxation in human pulmonary vessels.G Pussard, J P Gascard, I Gorenne, C Labat, X Norel, E Dulmet and C BrinkJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 969-975;
Gough, B
- You have accessAmphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects.P Clausing, B Gough, R R Holson, W Slikker and J F BowyerJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 614-621;
Graham, J H
- You have accessThe effect of cocaine and other local anesthetics on central dopaminergic neurotransmission.J H Graham, J R Maher and S E RobinsonJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 707-717;
Grélot, L
- You have accessThe piglet as a suitable animal model for studying the delayed phase of cisplatin-induced emesis.S Milano, P Blower, D Romain and L GrélotJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 951-961;
Griffith, R C
- You have accessNeuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemia.G C Palmer, E C Cregan, A R Borrelli, E W Harris, M L Stagnitto, P Colombo, F C Kaiser, R J Murray, R C Griffith and J C StrandJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 991-1000;
Guia, A
- You have accessEffects of phenamil on potassium and calcium channels of guinea pig ventricular myocytes.A Guia, N Leblanc and R BoseJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 649-656;
Gustin, P
- You have accessEndogenous nitric oxide modulates acetylcholine-induced edema and vasoconstriction in isolated perfused rabbit lungs.A Delaunois, P Gustin and M AnsayJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 559-597;
GUSTIN, P.
- You have accessEndogenous Nitric Oxide Modulates Acetylcholine-induced Edema and Vasoconstriction in Isolated Perfused Rabbit LungsA. DELAUNOIS, P. GUSTIN and M. ANSAYJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 589-597;
H
Hales, T G
- You have accessModulation of the GABAA receptor by propofol is independent of the gamma subunit.M V Jones, N L Harrison, D B Pritchett and T G HalesJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 962-968;
Halterman, T J
- You have accessZENECA ZD6169: a novel KATP channel opener with in vivo selectivity for urinary bladder.B B Howe, T J Halterman, C L Yochim, M L Do, S J Pettinger, R B Stow, C J Ohnmacht, K Russell, J R Empfield and D A TrainorJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 884-890;
Hammarlund-Udenaes, M
- You have accessProlactin release after remoxipride by an integrated pharmacokinetic-pharmacodynamic model with intra- and interindividual aspects.G Movin-Osswald and M Hammarlund-UdenaesJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 921-927;
Harris, E W
- You have accessNeuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemia.G C Palmer, E C Cregan, A R Borrelli, E W Harris, M L Stagnitto, P Colombo, F C Kaiser, R J Murray, R C Griffith and J C StrandJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 991-1000;
Harrison, N L
- You have accessModulation of the GABAA receptor by propofol is independent of the gamma subunit.M V Jones, N L Harrison, D B Pritchett and T G HalesJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 962-968;
Hasegawa, H
- You have accessAmeliorative effects of tea catechins on active oxygen-related nerve cell injuries.Y Matsuoka, H Hasegawa, S Okuda, T Muraki, T Uruno and K KubotaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 602-608;
Heffner, T G
- You have accessCI-1007, a dopamine partial agonist and potential antipsychotic agent. II. Neurophysiological and behavioral effects.L T Meltzer, C L Christoffersen, A E Corbin, F W Ninteman, K A Serpa, J N Wiley, L D Wise and T G HeffnerJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 912-920;
Hexum, T D
- You have accessNeuropeptide Y (18-36) modulates chromaffin cell catecholamine secretion by blocking the nicotinic receptor ion channel.J Zheng, R A Morrisett, J Zhu and T D HexumJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 891-897;
Hiraoka, A
- You have accessEnhancement of tobramycin binding to rat renal brush border membrane by vancomycin.Y Yano, A Hiraoka and T OgumaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 695-699;
Holmes, B B
- You have accessCold water swim stress- and delta-2 opioid-induced analgesia are modulated by spinal gamma-aminobutyric acidA receptors.P Killian, B B Holmes, A E Takemori, P S Portoghese and J M FujimotoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 730-734;
Holson, R R
- You have accessAmphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects.P Clausing, B Gough, R R Holson, W Slikker and J F BowyerJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 614-621;
Hong, J S
- You have accessEffects of sulpiride and SCH 23390 on methamphetamine-induced changes in body temperature and lethality.D M Bronstein and J S HongJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 943-950;
Houston, J B
- You have accessPrediction of in vivo disposition from in vitro systems: clearance of phenytoin and tolbutamide using rat hepatic microsomal and hepatocyte data.E I Ashforth, D J Carlile, R Chenery and J B HoustonJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 761-766;
Howe, B B
- You have accessZENECA ZD6169: a novel KATP channel opener with in vivo selectivity for urinary bladder.B B Howe, T J Halterman, C L Yochim, M L Do, S J Pettinger, R B Stow, C J Ohnmacht, K Russell, J R Empfield and D A TrainorJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 884-890;
Hull, W
- You have accessComparison of the distinct effects of epidermal growth factor and betamethasone on the morphogenesis of the gas exchange region and differentiation of alveolar type II cells in lungs of fetal rhesus monkeys.L A Edwards, L C Read, S J Nishio, A J Weir, W Hull, S Barry, D Styne, J A Whitsett, A F Tarantal and C George-NascimentoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 1025-1032;
I
Igarashi, T
- You have accessdelta 9-Tetrahydrocannabinol (THC) causes the variable expression of IL2 receptor subunits.W Zhu, T Igarashi, H Friedman and T W KleinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 1001-1007;
Insel, P A
- You have accessColchicine and cytochalasin B enhance cyclic AMP accumulation via postreceptor actions.J R Jasper, S R Post, K H Desai, P A Insel and D BernsteinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 937-942;
Irwin, R P
- You have accessDiphenylhydantoin induces apoptotic cell death of cultured rat cerebellar granule neurons.G M Yan, R P Irwin, S Z Lin, M Weller, K A Wood and S M PaulJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 983-990;
Ishima, T
- You have accessIrsogladine activates gap-junctional intercellular communication through M1 muscarinic acetylcholine receptor.F Ueda, K Ban and T IshimaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 815-819;
Iwamoto, Y
- You have accessModification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes.J Kamei, M Ohsawa, A Saitoh, Y Iwamoto, T Suzuki, M Misawa, H Nagase and Y KasuyaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 700-706;
J
Jasper, J R
- You have accessColchicine and cytochalasin B enhance cyclic AMP accumulation via postreceptor actions.J R Jasper, S R Post, K H Desai, P A Insel and D BernsteinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 937-942;
Jones, M V
- You have accessModulation of the GABAA receptor by propofol is independent of the gamma subunit.M V Jones, N L Harrison, D B Pritchett and T G HalesJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 962-968;
K
Kaiser, F C
- You have accessNeuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemia.G C Palmer, E C Cregan, A R Borrelli, E W Harris, M L Stagnitto, P Colombo, F C Kaiser, R J Murray, R C Griffith and J C StrandJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 991-1000;
Kamei, J
- You have accessModification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes.J Kamei, M Ohsawa, A Saitoh, Y Iwamoto, T Suzuki, M Misawa, H Nagase and Y KasuyaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 700-706;
Kaminski, D L
- You have accessRifampicin induction of lidocaine metabolism in cultured human hepatocytes.A P Li, A Rasmussen, L Xu and D L KaminskiJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 673-677;
Kantak, K M
- You have accessEffects of N-methyl-D-aspartate antagonists in rats discriminating different doses of cocaine: comparison with direct and indirect dopamine agonists.K M Kantak, M A Edwards and R D SpealmanJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 657-665;
Kasuya, Y
- You have accessModification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes.J Kamei, M Ohsawa, A Saitoh, Y Iwamoto, T Suzuki, M Misawa, H Nagase and Y KasuyaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 700-706;
Katofiasc, M A
- You have accessEffects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat.K B Thor and M A KatofiascJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 1014-1024;
Kelly, J J
- You have accessCharacterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma.C D Nicholson, M Shahid, J Bruin, E Barron, I Spiers, J de Boer, R G van Amsterdam, J Zaagsma, J J Kelly and G DentJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 678-687;
Killian, P
- You have accessCold water swim stress- and delta-2 opioid-induced analgesia are modulated by spinal gamma-aminobutyric acidA receptors.P Killian, B B Holmes, A E Takemori, P S Portoghese and J M FujimotoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 730-734;
Klein, T W
- You have accessdelta 9-Tetrahydrocannabinol (THC) causes the variable expression of IL2 receptor subunits.W Zhu, T Igarashi, H Friedman and T W KleinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 1001-1007;
Konkoy, C S
- You have accessNeuropeptide metabolism on intact, regional brain slices: effect of dopaminergic agents on substance P, cholecystokinin and Met-enkephalin degradation.S M Waters, C S Konkoy and T P DavisJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 783-789;
Kreiss, D S
- You have accessEffects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo.D S Kreiss and I LuckiJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 866-876;
Kubota, K
- You have accessAmeliorative effects of tea catechins on active oxygen-related nerve cell injuries.Y Matsuoka, H Hasegawa, S Okuda, T Muraki, T Uruno and K KubotaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 602-608;
L
Labat, C
- You have accessEndothelin-1 modulates cyclic GMP production and relaxation in human pulmonary vessels.G Pussard, J P Gascard, I Gorenne, C Labat, X Norel, E Dulmet and C BrinkJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 969-975;
Landino, P
- You have accessProtective role of chronic ubiquinone administration on acute cardiac oxidative stress.N Ferrara, P Abete, G Ambrosio, P Landino, P Caccese, P Cirillo, A Oradei, G P Littarru, M Chiariello and F RengoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 858-865;
Lark, L A
- You have accessCardiovascular effects after the intracerebroventricular administration of peptide and nonpeptide angiotensin antagonists in Dahl salt-sensitive rats.L A Lark, S M Wappel and J A WeyhenmeyerJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 745-751;
Latinne, D
- You have accessThe in vitro immunosuppressive activity of the C15-demethylated metabolite of FK-506 is governed by ring- and open-chain tautomerism effects.G Lhoëst, R K Verbeeck, N Maton, P Muthelet and D LatinneJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 622-626;
Leblanc, N
- You have accessEffects of phenamil on potassium and calcium channels of guinea pig ventricular myocytes.A Guia, N Leblanc and R BoseJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 649-656;
Lefebvre, R A
- You have accessCisapride and structural analogs selectively enhance 5-hydroxytryptamine (5-HT)-induced purinergic neurotransmission in the guinea pig proximal colon.M R Briejer, G J Veen, L M Akkermans, R A Lefebvre and J A SchuurkesJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 641-648;
Lhoëst, G
- You have accessThe in vitro immunosuppressive activity of the C15-demethylated metabolite of FK-506 is governed by ring- and open-chain tautomerism effects.G Lhoëst, R K Verbeeck, N Maton, P Muthelet and D LatinneJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 622-626;
Li, A P
- You have accessRifampicin induction of lidocaine metabolism in cultured human hepatocytes.A P Li, A Rasmussen, L Xu and D L KaminskiJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 673-677;
Lin, S Z
- You have accessDiphenylhydantoin induces apoptotic cell death of cultured rat cerebellar granule neurons.G M Yan, R P Irwin, S Z Lin, M Weller, K A Wood and S M PaulJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 983-990;
Littarru, G P
- You have accessProtective role of chronic ubiquinone administration on acute cardiac oxidative stress.N Ferrara, P Abete, G Ambrosio, P Landino, P Caccese, P Cirillo, A Oradei, G P Littarru, M Chiariello and F RengoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 858-865;
Lucki, I
- You have accessEffects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo.D S Kreiss and I LuckiJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 866-876;
Luthin, G R
- You have accessHuman prostate muscarinic receptor subtypes.M R Ruggieri, M D Colton, P Wang, J Wang, R J Smyth, M A Pontari and G R LuthinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 976-982;
M
MacKenzie, R G
- You have accessCI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.T A Rugsley, M D Davis, H C Akunne, L W Cooke, S Z Whetzel, R G MacKenzie, Y H Shih, D H van Leeuwen, S B DeMattos and L M GeorgicJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 898-911;
Maher, J R
- You have accessThe effect of cocaine and other local anesthetics on central dopaminergic neurotransmission.J H Graham, J R Maher and S E RobinsonJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 707-717;
Malmberg, A
- You have accessCharacterization of [3H]quinpirole binding to human dopamine D2A and D3 receptors: effects of ions and guanine nucleotides.A Malmberg and N MohellJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 790-797;
Mamber, S W
- You have accessTubulin polymerization by paclitaxel (taxol) phosphate prodrugs after metabolic activation with alkaline phosphatase.S W Mamber, A B Mikkilineni, E J Pack, M P Rosser, H Wong, Y Ueda and S ForenzaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 877-883;
Marks, M J
- You have accessSodium channel blockers partially inhibit nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomes.M J Marks, A E Bullock and A C CollinsJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 833-841;
Maton, N
- You have accessThe in vitro immunosuppressive activity of the C15-demethylated metabolite of FK-506 is governed by ring- and open-chain tautomerism effects.G Lhoëst, R K Verbeeck, N Maton, P Muthelet and D LatinneJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 622-626;
Matsuoka, Y
- You have accessAmeliorative effects of tea catechins on active oxygen-related nerve cell injuries.Y Matsuoka, H Hasegawa, S Okuda, T Muraki, T Uruno and K KubotaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 602-608;
Meltzer, L T
- You have accessCI-1007, a dopamine partial agonist and potential antipsychotic agent. II. Neurophysiological and behavioral effects.L T Meltzer, C L Christoffersen, A E Corbin, F W Ninteman, K A Serpa, J N Wiley, L D Wise and T G HeffnerJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 912-920;
Mikkilineni, A B
- You have accessTubulin polymerization by paclitaxel (taxol) phosphate prodrugs after metabolic activation with alkaline phosphatase.S W Mamber, A B Mikkilineni, E J Pack, M P Rosser, H Wong, Y Ueda and S ForenzaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 877-883;
Milano, S
- You have accessThe piglet as a suitable animal model for studying the delayed phase of cisplatin-induced emesis.S Milano, P Blower, D Romain and L GrélotJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 951-961;
Misawa, M
- You have accessModification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes.J Kamei, M Ohsawa, A Saitoh, Y Iwamoto, T Suzuki, M Misawa, H Nagase and Y KasuyaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 700-706;
Mohell, N
- You have accessCharacterization of [3H]quinpirole binding to human dopamine D2A and D3 receptors: effects of ions and guanine nucleotides.A Malmberg and N MohellJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 790-797;
Morrisett, R A
- You have accessNeuropeptide Y (18-36) modulates chromaffin cell catecholamine secretion by blocking the nicotinic receptor ion channel.J Zheng, R A Morrisett, J Zhu and T D HexumJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 891-897;
Moss, D E
- You have accessCholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.G Pacheco, R Palacios-Esquivel and D E MossJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 767-770;
Movin-Osswald, G
- You have accessProlactin release after remoxipride by an integrated pharmacokinetic-pharmacodynamic model with intra- and interindividual aspects.G Movin-Osswald and M Hammarlund-UdenaesJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 921-927;
Muraki, T
- You have accessAmeliorative effects of tea catechins on active oxygen-related nerve cell injuries.Y Matsuoka, H Hasegawa, S Okuda, T Muraki, T Uruno and K KubotaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 602-608;
Murray, R J
- You have accessNeuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemia.G C Palmer, E C Cregan, A R Borrelli, E W Harris, M L Stagnitto, P Colombo, F C Kaiser, R J Murray, R C Griffith and J C StrandJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 991-1000;
Muthelet, P
- You have accessThe in vitro immunosuppressive activity of the C15-demethylated metabolite of FK-506 is governed by ring- and open-chain tautomerism effects.G Lhoëst, R K Verbeeck, N Maton, P Muthelet and D LatinneJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 622-626;
N
Nagase, H
- You have accessModification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes.J Kamei, M Ohsawa, A Saitoh, Y Iwamoto, T Suzuki, M Misawa, H Nagase and Y KasuyaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 700-706;
Nathaniel, P
- You have accessRitanserin, a 5-HT2A/2C antagonist, reverses direct dopamine agonist-induced inhibition of midbrain dopamine neurons.W X Shi, P Nathaniel and B S BunneyJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 735-740;
Negus, S S
- You have accessEffects of morphine and ketorolac on thermal allodynia induced by prostaglandin E2 and bradykinin in rhesus monkeys.S S Negus, E R Butelman, M B Gatch and J H WoodsJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 805-814;
Nicholson, C D
- You have accessCharacterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma.C D Nicholson, M Shahid, J Bruin, E Barron, I Spiers, J de Boer, R G van Amsterdam, J Zaagsma, J J Kelly and G DentJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 678-687;
Ninteman, F W
- You have accessCI-1007, a dopamine partial agonist and potential antipsychotic agent. II. Neurophysiological and behavioral effects.L T Meltzer, C L Christoffersen, A E Corbin, F W Ninteman, K A Serpa, J N Wiley, L D Wise and T G HeffnerJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 912-920;
Nishio, S J
- You have accessComparison of the distinct effects of epidermal growth factor and betamethasone on the morphogenesis of the gas exchange region and differentiation of alveolar type II cells in lungs of fetal rhesus monkeys.L A Edwards, L C Read, S J Nishio, A J Weir, W Hull, S Barry, D Styne, J A Whitsett, A F Tarantal and C George-NascimentoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 1025-1032;
Norel, X
- You have accessEndothelin-1 modulates cyclic GMP production and relaxation in human pulmonary vessels.G Pussard, J P Gascard, I Gorenne, C Labat, X Norel, E Dulmet and C BrinkJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 969-975;
O
Oguma, T
- You have accessEnhancement of tobramycin binding to rat renal brush border membrane by vancomycin.Y Yano, A Hiraoka and T OgumaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 695-699;
Ohnmacht, C J
- You have accessZENECA ZD6169: a novel KATP channel opener with in vivo selectivity for urinary bladder.B B Howe, T J Halterman, C L Yochim, M L Do, S J Pettinger, R B Stow, C J Ohnmacht, K Russell, J R Empfield and D A TrainorJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 884-890;
Ohsawa, M
- You have accessModification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes.J Kamei, M Ohsawa, A Saitoh, Y Iwamoto, T Suzuki, M Misawa, H Nagase and Y KasuyaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 700-706;
Okuda, S
- You have accessAmeliorative effects of tea catechins on active oxygen-related nerve cell injuries.Y Matsuoka, H Hasegawa, S Okuda, T Muraki, T Uruno and K KubotaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 602-608;
Ono, M
- You have accessInvolvement of dopamine, N-methyl-D-aspartate and sigma receptor mechanisms in methamphetamine-induced anticipatory activity rhythm in rats.S Shibata, M Ono, N Fukuhara and S WatanabeJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 688-694;
Oradei, A
- You have accessProtective role of chronic ubiquinone administration on acute cardiac oxidative stress.N Ferrara, P Abete, G Ambrosio, P Landino, P Caccese, P Cirillo, A Oradei, G P Littarru, M Chiariello and F RengoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 858-865;
P
Pacheco, G
- You have accessCholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.G Pacheco, R Palacios-Esquivel and D E MossJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 767-770;
Pack, E J
- You have accessTubulin polymerization by paclitaxel (taxol) phosphate prodrugs after metabolic activation with alkaline phosphatase.S W Mamber, A B Mikkilineni, E J Pack, M P Rosser, H Wong, Y Ueda and S ForenzaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 877-883;
Palacios-Esquivel, R
- You have accessCholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.G Pacheco, R Palacios-Esquivel and D E MossJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 767-770;
Palmer, G C
- You have accessNeuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemia.G C Palmer, E C Cregan, A R Borrelli, E W Harris, M L Stagnitto, P Colombo, F C Kaiser, R J Murray, R C Griffith and J C StrandJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 991-1000;
Paul, S M
- You have accessDiphenylhydantoin induces apoptotic cell death of cultured rat cerebellar granule neurons.G M Yan, R P Irwin, S Z Lin, M Weller, K A Wood and S M PaulJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 983-990;
Pettinger, S J
- You have accessZENECA ZD6169: a novel KATP channel opener with in vivo selectivity for urinary bladder.B B Howe, T J Halterman, C L Yochim, M L Do, S J Pettinger, R B Stow, C J Ohnmacht, K Russell, J R Empfield and D A TrainorJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 884-890;
Piffeteau, A
- You have accessNitric oxide formation during the cytochrome P-450-dependent reductive metabolism of 18-nitro-oxyandrostenedione.M Delaforge, A Piffeteau, J L Boucher and A VigerJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 634-640;
Plotkine, M
- You have accessAnalgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat.F Stain, M J Barjavel, P Sandouk, M Plotkine, J M Scherrmann and H N BhargavaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 852-857;
Pontari, M A
- You have accessHuman prostate muscarinic receptor subtypes.M R Ruggieri, M D Colton, P Wang, J Wang, R J Smyth, M A Pontari and G R LuthinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 976-982;
Portoghese, P S
- You have accessCold water swim stress- and delta-2 opioid-induced analgesia are modulated by spinal gamma-aminobutyric acidA receptors.P Killian, B B Holmes, A E Takemori, P S Portoghese and J M FujimotoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 730-734;
Post, S R
- You have accessColchicine and cytochalasin B enhance cyclic AMP accumulation via postreceptor actions.J R Jasper, S R Post, K H Desai, P A Insel and D BernsteinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 937-942;
Premkumar, L S
- You have accessBlockade of a resting potassium channel and modulation of synaptic transmission by ecstasy in the hippocampus.L S Premkumar and G P AhernJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 718-722;
Pritchett, D B
- You have accessModulation of the GABAA receptor by propofol is independent of the gamma subunit.M V Jones, N L Harrison, D B Pritchett and T G HalesJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 962-968;
Pussard, G
- You have accessEndothelin-1 modulates cyclic GMP production and relaxation in human pulmonary vessels.G Pussard, J P Gascard, I Gorenne, C Labat, X Norel, E Dulmet and C BrinkJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 969-975;
R
Randall, S
- You have accessThe neurokinin1 receptor antagonist CP-99,994 reduces catalepsy produced by the dopamine D2 receptor antagonist raclopride: correlation with extracellular acetylcholine levels in striatum.J J Anderson, S Randall and T N ChaseJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 928-936;
Rasmussen, A
- You have accessRifampicin induction of lidocaine metabolism in cultured human hepatocytes.A P Li, A Rasmussen, L Xu and D L KaminskiJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 673-677;
Read, L C
- You have accessComparison of the distinct effects of epidermal growth factor and betamethasone on the morphogenesis of the gas exchange region and differentiation of alveolar type II cells in lungs of fetal rhesus monkeys.L A Edwards, L C Read, S J Nishio, A J Weir, W Hull, S Barry, D Styne, J A Whitsett, A F Tarantal and C George-NascimentoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 1025-1032;
Rengo, F
- You have accessProtective role of chronic ubiquinone administration on acute cardiac oxidative stress.N Ferrara, P Abete, G Ambrosio, P Landino, P Caccese, P Cirillo, A Oradei, G P Littarru, M Chiariello and F RengoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 858-865;
Robinson, S E
- You have accessThe effect of cocaine and other local anesthetics on central dopaminergic neurotransmission.J H Graham, J R Maher and S E RobinsonJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 707-717;
Romain, D
- You have accessThe piglet as a suitable animal model for studying the delayed phase of cisplatin-induced emesis.S Milano, P Blower, D Romain and L GrélotJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 951-961;
Rosenzweig-Lipson, S
- You have accessModification of the behavioral effects of (+/-)BAY k 8644, cocaine and d-amphetamine by L-type calcium channel blockers in squirrel monkeys.S Rosenzweig-Lipson and J E BarrettJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 842-851;
Rosser, M P
- You have accessTubulin polymerization by paclitaxel (taxol) phosphate prodrugs after metabolic activation with alkaline phosphatase.S W Mamber, A B Mikkilineni, E J Pack, M P Rosser, H Wong, Y Ueda and S ForenzaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 877-883;
Rudin, M
- You have accessStrain-dependent drug effects in rat middle cerebral artery occlusion model of stroke.A Sauter and M RudinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 1008-1013;
Ruggieri, M R
- You have accessHuman prostate muscarinic receptor subtypes.M R Ruggieri, M D Colton, P Wang, J Wang, R J Smyth, M A Pontari and G R LuthinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 976-982;
Rugsley, T A
- You have accessCI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.T A Rugsley, M D Davis, H C Akunne, L W Cooke, S Z Whetzel, R G MacKenzie, Y H Shih, D H van Leeuwen, S B DeMattos and L M GeorgicJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 898-911;
Russell, K
- You have accessZENECA ZD6169: a novel KATP channel opener with in vivo selectivity for urinary bladder.B B Howe, T J Halterman, C L Yochim, M L Do, S J Pettinger, R B Stow, C J Ohnmacht, K Russell, J R Empfield and D A TrainorJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 884-890;
S
Saitoh, A
- You have accessModification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes.J Kamei, M Ohsawa, A Saitoh, Y Iwamoto, T Suzuki, M Misawa, H Nagase and Y KasuyaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 700-706;
Sandouk, P
- You have accessAnalgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat.F Stain, M J Barjavel, P Sandouk, M Plotkine, J M Scherrmann and H N BhargavaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 852-857;
Sauter, A
- You have accessStrain-dependent drug effects in rat middle cerebral artery occlusion model of stroke.A Sauter and M RudinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 1008-1013;
Scherrmann, J M
- You have accessAnalgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat.F Stain, M J Barjavel, P Sandouk, M Plotkine, J M Scherrmann and H N BhargavaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 852-857;
Schuurkes, J A
- You have accessCisapride and structural analogs selectively enhance 5-hydroxytryptamine (5-HT)-induced purinergic neurotransmission in the guinea pig proximal colon.M R Briejer, G J Veen, L M Akkermans, R A Lefebvre and J A SchuurkesJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 641-648;
Serpa, K A
- You have accessCI-1007, a dopamine partial agonist and potential antipsychotic agent. II. Neurophysiological and behavioral effects.L T Meltzer, C L Christoffersen, A E Corbin, F W Ninteman, K A Serpa, J N Wiley, L D Wise and T G HeffnerJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 912-920;
Shahid, M
- You have accessCharacterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma.C D Nicholson, M Shahid, J Bruin, E Barron, I Spiers, J de Boer, R G van Amsterdam, J Zaagsma, J J Kelly and G DentJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 678-687;
Sheldon, J H
- You have accessAcute administration of 17 beta-estradiol inhibits calcium currents in isolated guinea pig detrusor myocytes.J H Sheldon and T M ArgentieriJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 723-729;
Shi, W X
- You have accessRitanserin, a 5-HT2A/2C antagonist, reverses direct dopamine agonist-induced inhibition of midbrain dopamine neurons.W X Shi, P Nathaniel and B S BunneyJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 735-740;
Shibata, S
- You have accessInvolvement of dopamine, N-methyl-D-aspartate and sigma receptor mechanisms in methamphetamine-induced anticipatory activity rhythm in rats.S Shibata, M Ono, N Fukuhara and S WatanabeJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 688-694;
Shih, Y H
- You have accessCI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.T A Rugsley, M D Davis, H C Akunne, L W Cooke, S Z Whetzel, R G MacKenzie, Y H Shih, D H van Leeuwen, S B DeMattos and L M GeorgicJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 898-911;
Sinha, A
- You have accessDopamine D3-preferring ligands act at synthesis modulating autoreceptors.C W Aretha, A Sinha and M P GallowayJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 609-613;
Slikker, W
- You have accessAmphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects.P Clausing, B Gough, R R Holson, W Slikker and J F BowyerJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 614-621;
Smyth, D D
- You have accessEfaroxan acts peripherally to block the antisecretory and gastroprotective effects of moxonidine in rats.M A Carlisle, D D Smyth and G B GlavinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 598-601;
- You have accessAgmatine, an endogenous imidazoline receptor agonist, increases gastric secretion and worsens experimental gastric mucosal injury in rats.G B Glavin, M A Carlisle and D D SmythJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 741-744;
Smyth, R J
- You have accessHuman prostate muscarinic receptor subtypes.M R Ruggieri, M D Colton, P Wang, J Wang, R J Smyth, M A Pontari and G R LuthinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 976-982;
Spealman, R D
- You have accessEffects of N-methyl-D-aspartate antagonists in rats discriminating different doses of cocaine: comparison with direct and indirect dopamine agonists.K M Kantak, M A Edwards and R D SpealmanJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 657-665;
Spiers, I
- You have accessCharacterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma.C D Nicholson, M Shahid, J Bruin, E Barron, I Spiers, J de Boer, R G van Amsterdam, J Zaagsma, J J Kelly and G DentJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 678-687;
Stagnitto, M L
- You have accessNeuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemia.G C Palmer, E C Cregan, A R Borrelli, E W Harris, M L Stagnitto, P Colombo, F C Kaiser, R J Murray, R C Griffith and J C StrandJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 991-1000;
Stain, F
- You have accessAnalgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat.F Stain, M J Barjavel, P Sandouk, M Plotkine, J M Scherrmann and H N BhargavaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 852-857;
Stow, R B
- You have accessZENECA ZD6169: a novel KATP channel opener with in vivo selectivity for urinary bladder.B B Howe, T J Halterman, C L Yochim, M L Do, S J Pettinger, R B Stow, C J Ohnmacht, K Russell, J R Empfield and D A TrainorJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 884-890;
Strand, J C
- You have accessNeuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemia.G C Palmer, E C Cregan, A R Borrelli, E W Harris, M L Stagnitto, P Colombo, F C Kaiser, R J Murray, R C Griffith and J C StrandJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 991-1000;
Styne, D
- You have accessComparison of the distinct effects of epidermal growth factor and betamethasone on the morphogenesis of the gas exchange region and differentiation of alveolar type II cells in lungs of fetal rhesus monkeys.L A Edwards, L C Read, S J Nishio, A J Weir, W Hull, S Barry, D Styne, J A Whitsett, A F Tarantal and C George-NascimentoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 1025-1032;
Suzuki, T
- You have accessModification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes.J Kamei, M Ohsawa, A Saitoh, Y Iwamoto, T Suzuki, M Misawa, H Nagase and Y KasuyaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 700-706;
Sweeney, K R
- You have accessThe influence of protein binding on the elimination of acetazolamide by the isolated perfused rat kidney: evidence of albumin-mediated tubular secretion.D R Taft and K R SweeneyJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 752-760;
T
Taft, D R
- You have accessThe influence of protein binding on the elimination of acetazolamide by the isolated perfused rat kidney: evidence of albumin-mediated tubular secretion.D R Taft and K R SweeneyJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 752-760;
Takemori, A E
- You have accessCold water swim stress- and delta-2 opioid-induced analgesia are modulated by spinal gamma-aminobutyric acidA receptors.P Killian, B B Holmes, A E Takemori, P S Portoghese and J M FujimotoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 730-734;
Tarantal, A F
- You have accessComparison of the distinct effects of epidermal growth factor and betamethasone on the morphogenesis of the gas exchange region and differentiation of alveolar type II cells in lungs of fetal rhesus monkeys.L A Edwards, L C Read, S J Nishio, A J Weir, W Hull, S Barry, D Styne, J A Whitsett, A F Tarantal and C George-NascimentoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 1025-1032;
Thor, K B
- You have accessEffects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat.K B Thor and M A KatofiascJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 1014-1024;
- You have accessPharmacological analysis of the noradrenergic control of central sympathetic and somatic reflexes controlling the lower urinary tract in the anesthetized cat.H Danuser, K Bemis and K B ThorJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 820-825;
Trainor, D A
- You have accessZENECA ZD6169: a novel KATP channel opener with in vivo selectivity for urinary bladder.B B Howe, T J Halterman, C L Yochim, M L Do, S J Pettinger, R B Stow, C J Ohnmacht, K Russell, J R Empfield and D A TrainorJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 884-890;
Trautwein, W
- You have accessInhibition of L-type calcium currents in guinea pig ventricular myocytes by the kappa-opioid agonist U50488H does not involve binding to opiate receptors.J Utz, R Eckert and W TrautweinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 627-633;
U
Ueda, F
- You have accessIrsogladine activates gap-junctional intercellular communication through M1 muscarinic acetylcholine receptor.F Ueda, K Ban and T IshimaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 815-819;
Ueda, Y
- You have accessTubulin polymerization by paclitaxel (taxol) phosphate prodrugs after metabolic activation with alkaline phosphatase.S W Mamber, A B Mikkilineni, E J Pack, M P Rosser, H Wong, Y Ueda and S ForenzaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 877-883;
Uruno, T
- You have accessAmeliorative effects of tea catechins on active oxygen-related nerve cell injuries.Y Matsuoka, H Hasegawa, S Okuda, T Muraki, T Uruno and K KubotaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 602-608;
Utz, J
- You have accessInhibition of L-type calcium currents in guinea pig ventricular myocytes by the kappa-opioid agonist U50488H does not involve binding to opiate receptors.J Utz, R Eckert and W TrautweinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 627-633;
V
van Amsterdam, R G
- You have accessCharacterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma.C D Nicholson, M Shahid, J Bruin, E Barron, I Spiers, J de Boer, R G van Amsterdam, J Zaagsma, J J Kelly and G DentJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 678-687;
van Leeuwen, D H
- You have accessCI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.T A Rugsley, M D Davis, H C Akunne, L W Cooke, S Z Whetzel, R G MacKenzie, Y H Shih, D H van Leeuwen, S B DeMattos and L M GeorgicJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 898-911;
VanRollins, M
- You have accessEpoxygenase metabolites of docosahexaenoic and eicosapentaenoic acids inhibit platelet aggregation at concentrations below those affecting thromboxane synthesis.M VanRollinsJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 798-804;
Veen, G J
- You have accessCisapride and structural analogs selectively enhance 5-hydroxytryptamine (5-HT)-induced purinergic neurotransmission in the guinea pig proximal colon.M R Briejer, G J Veen, L M Akkermans, R A Lefebvre and J A SchuurkesJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 641-648;
Verbeeck, R K
- You have accessThe in vitro immunosuppressive activity of the C15-demethylated metabolite of FK-506 is governed by ring- and open-chain tautomerism effects.G Lhoëst, R K Verbeeck, N Maton, P Muthelet and D LatinneJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 622-626;
Viger, A
- You have accessNitric oxide formation during the cytochrome P-450-dependent reductive metabolism of 18-nitro-oxyandrostenedione.M Delaforge, A Piffeteau, J L Boucher and A VigerJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 634-640;
W
Wang, J
- You have accessHuman prostate muscarinic receptor subtypes.M R Ruggieri, M D Colton, P Wang, J Wang, R J Smyth, M A Pontari and G R LuthinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 976-982;
Wang, P
- You have accessHuman prostate muscarinic receptor subtypes.M R Ruggieri, M D Colton, P Wang, J Wang, R J Smyth, M A Pontari and G R LuthinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 976-982;
Wappel, S M
- You have accessCardiovascular effects after the intracerebroventricular administration of peptide and nonpeptide angiotensin antagonists in Dahl salt-sensitive rats.L A Lark, S M Wappel and J A WeyhenmeyerJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 745-751;
Watanabe, S
- You have accessInvolvement of dopamine, N-methyl-D-aspartate and sigma receptor mechanisms in methamphetamine-induced anticipatory activity rhythm in rats.S Shibata, M Ono, N Fukuhara and S WatanabeJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 688-694;
Waters, S M
- You have accessNeuropeptide metabolism on intact, regional brain slices: effect of dopaminergic agents on substance P, cholecystokinin and Met-enkephalin degradation.S M Waters, C S Konkoy and T P DavisJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 783-789;
Weir, A J
- You have accessComparison of the distinct effects of epidermal growth factor and betamethasone on the morphogenesis of the gas exchange region and differentiation of alveolar type II cells in lungs of fetal rhesus monkeys.L A Edwards, L C Read, S J Nishio, A J Weir, W Hull, S Barry, D Styne, J A Whitsett, A F Tarantal and C George-NascimentoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 1025-1032;
Weller, M
- You have accessDiphenylhydantoin induces apoptotic cell death of cultured rat cerebellar granule neurons.G M Yan, R P Irwin, S Z Lin, M Weller, K A Wood and S M PaulJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 983-990;
Weyhenmeyer, J A
- You have accessCardiovascular effects after the intracerebroventricular administration of peptide and nonpeptide angiotensin antagonists in Dahl salt-sensitive rats.L A Lark, S M Wappel and J A WeyhenmeyerJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 745-751;
Whetzel, S Z
- You have accessCI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.T A Rugsley, M D Davis, H C Akunne, L W Cooke, S Z Whetzel, R G MacKenzie, Y H Shih, D H van Leeuwen, S B DeMattos and L M GeorgicJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 898-911;
Whitsett, J A
- You have accessComparison of the distinct effects of epidermal growth factor and betamethasone on the morphogenesis of the gas exchange region and differentiation of alveolar type II cells in lungs of fetal rhesus monkeys.L A Edwards, L C Read, S J Nishio, A J Weir, W Hull, S Barry, D Styne, J A Whitsett, A F Tarantal and C George-NascimentoJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 1025-1032;
Wiley, J N
- You have accessCI-1007, a dopamine partial agonist and potential antipsychotic agent. II. Neurophysiological and behavioral effects.L T Meltzer, C L Christoffersen, A E Corbin, F W Ninteman, K A Serpa, J N Wiley, L D Wise and T G HeffnerJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 912-920;
Wise, L D
- You have accessCI-1007, a dopamine partial agonist and potential antipsychotic agent. II. Neurophysiological and behavioral effects.L T Meltzer, C L Christoffersen, A E Corbin, F W Ninteman, K A Serpa, J N Wiley, L D Wise and T G HeffnerJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 912-920;
Wong, H
- You have accessTubulin polymerization by paclitaxel (taxol) phosphate prodrugs after metabolic activation with alkaline phosphatase.S W Mamber, A B Mikkilineni, E J Pack, M P Rosser, H Wong, Y Ueda and S ForenzaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 877-883;
Wood, K A
- You have accessDiphenylhydantoin induces apoptotic cell death of cultured rat cerebellar granule neurons.G M Yan, R P Irwin, S Z Lin, M Weller, K A Wood and S M PaulJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 983-990;
Woods, J H
- You have accessEffects of morphine and ketorolac on thermal allodynia induced by prostaglandin E2 and bradykinin in rhesus monkeys.S S Negus, E R Butelman, M B Gatch and J H WoodsJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 805-814;
X
Xiao, W H
- You have accessSynthetic omega-conopeptides applied to the site of nerve injury suppress neuropathic pains in rats.W H Xiao and G J BennettJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 666-672;
Xu, L
- You have accessRifampicin induction of lidocaine metabolism in cultured human hepatocytes.A P Li, A Rasmussen, L Xu and D L KaminskiJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 673-677;
Y
Yan, G M
- You have accessDiphenylhydantoin induces apoptotic cell death of cultured rat cerebellar granule neurons.G M Yan, R P Irwin, S Z Lin, M Weller, K A Wood and S M PaulJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 983-990;
Yano, Y
- You have accessEnhancement of tobramycin binding to rat renal brush border membrane by vancomycin.Y Yano, A Hiraoka and T OgumaJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 695-699;
Yochim, C L
- You have accessZENECA ZD6169: a novel KATP channel opener with in vivo selectivity for urinary bladder.B B Howe, T J Halterman, C L Yochim, M L Do, S J Pettinger, R B Stow, C J Ohnmacht, K Russell, J R Empfield and D A TrainorJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 884-890;
Z
Zaagsma, J
- You have accessCharacterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma.C D Nicholson, M Shahid, J Bruin, E Barron, I Spiers, J de Boer, R G van Amsterdam, J Zaagsma, J J Kelly and G DentJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 678-687;
Zheng, J
- You have accessNeuropeptide Y (18-36) modulates chromaffin cell catecholamine secretion by blocking the nicotinic receptor ion channel.J Zheng, R A Morrisett, J Zhu and T D HexumJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 891-897;
Zhu, J
- You have accessNeuropeptide Y (18-36) modulates chromaffin cell catecholamine secretion by blocking the nicotinic receptor ion channel.J Zheng, R A Morrisett, J Zhu and T D HexumJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 891-897;
Zhu, W
- You have accessdelta 9-Tetrahydrocannabinol (THC) causes the variable expression of IL2 receptor subunits.W Zhu, T Igarashi, H Friedman and T W KleinJournal of Pharmacology and Experimental Therapeutics August 1995, 274 (2) 1001-1007;
In this issue

Advertisement